Pharmacon Enterprises Private Limited
About Pharmacon Enterprises Private Limited
Data last updated:
Pharmacon Enterprises Private Limited was a private limited company based in Srinagar, Jammu And Kashmir, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the medicinal chemical and botanical products segment of the chemicals sector. It was incorporated on 11 June 2009.
The company was registered with the Registrar of Companies (ROC), Jammu, under CIN U24239JK2009PTC003030.
The company had an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5.1 Lakh. It was led by directors Mohammad Ayub Khan (Managing Director) and Suhail Anwar.
Its last annual general meeting (AGM) was held on 29 September 2018, and its latest financial statements are for the year ended 31 March 2018. The registered office was at Shah Complex Opp. Medicare Diagonostic Center Karan Nagar, Srinagar, Jammu and Kashmir, India – 190010.
As per the financials filed for FY 2018, the company reported a revenue of ₹15.59 Lakh, a decline of 51% compared to the previous year. For the same year it recorded a net loss of ₹2,910 (net margin -0.2%) and EBITDA of ₹2,002 (EBITDA margin 0.1%). Revenue has declined at a compounded annual rate (CAGR) of 7% over three years.
Company details
Contact details
Pharmacon Enterprises Private Limited's registered office is in Srinagar, Jammu And Kashmir. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressShah Complex Opp. Medicare Diagonostic Center Karan Nagar, Srinagar, Jammu and Kashmir, India – 190010
- IndustryChemicals, Medicinal Chemical & Botanical Products, Pharmaceuticals, Chemical Products
To see the full contact details of Pharmacon Enterprises Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Pharmacon Enterprises is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Pharmacon Enterprises Private Limited, buy the company report.
Financials of Pharmacon Enterprises Private Limited
FY 2018 filings availablePharmacon Enterprises Private Limited reported revenue of ₹15.59 Lakh (down 51% YoY) for FY 2018.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 7% over three years, including a 51% fall in the latest year. EBITDA fell 75% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹2,002 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹2,910 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 0.1% | |||
| Net Profit Margin | -0.2% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Pharmacon Enterprises Private Limited, buy the company report.
Board of directors of Pharmacon Enterprises Private Limited
Pharmacon Enterprises has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Suhail Anwar Also directs: Caps & Scalpels Pharma Private Limited | Director | 12 Jun 2009 | 17 Years 4 Months | As last reported |
| Mohammad Ayub Khan | Managing Director | 11 Jun 2009 | 17 Years 4 Months | As last reported |
Peer comparison
Pharmacon Enterprises Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Gyp Craft Frames Private Limited | ₹15.6 Lakh (FY 2024) | Chennai, Tamil Nadu, India | ||||
| Sangli Grape Processing Marketing and Research Industry Limited | ₹15.6 Lakh (FY 2025) | 5975.0% | Malgaon, Maharashtra, India | |||
| Janta Fab Private Limited | ₹15.59 Lakh (FY 2025) | -51.0% | Rajasthan, India | |||
| Nucleus Microsystems Private Limited | ₹15.59 Lakh (FY 2025) | 26.0% | New Delhi, Delhi, India | |||
| Berryblues Retails Private Limited | ₹15.59 Lakh (FY 2025) | 131.0% | Kolkata, West Bengal, India | |||
| Pharmacon Enterprises Private Limitedthis company | ₹15.59 Lakh (FY 2018) | -₹2,910 | -0.2% | -51.0% | Srinagar, Jammu And Kashmir, India | |
| Agexporters Private Limited | ₹15.59 Lakh (FY 2022) | 53.0% | Ahmedabad, Gujarat, India | |||
| Opaass Healthcare Private Limited | ₹15.59 Lakh (FY 2024) | -49.0% | Kanpur, Uttar Pradesh, India | |||
| Ceras Intech Private Limited | ₹15.59 Lakh (FY 2024) | -16.0% | Chennai, Tamil Nadu, India | |||
| Regularvision Agrovet Private Limited | ₹15.58 Lakh (FY 2023) | 7.0% | Kolkata, West Bengal, India | |||
| Maxis Mart Private Limited | ₹15.58 Lakh (FY 2025) | 59.0% | Ghaziabad, Uttar Pradesh, India |
To see the full peer comparison of Pharmacon Enterprises Private Limited, buy the company report.
Auditor
Pharmacon Enterprises Private Limited is audited by SANJAY BISHAMBER & CO for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SANJAY BISHAMBER & CO | FY 2017 | 097187 |
Shareholding
The shareholding of Pharmacon Enterprises Private Limited is on record for 3 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Pharmacon Enterprises Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Pharmacon Enterprises Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Pharmacon Enterprises Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Pharmacon Enterprises Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Pharmacon Enterprises Private Limited has 5 board changes on record since 2009: 2 appointments and 3 cessations. The latest: Gazanfar Ali Jan ceased to be Director on 10 Jun 2019.
Frequently asked questions
Pharmacon Enterprises has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Pharmacon Enterprises was a private limited company based in Srinagar, Jammu And Kashmir, India. The company worked in medicinal chemical and botanical products, within the chemicals industry. It was incorporated on 11 June 2009 and is registered under CIN U24239JK2009PTC003030. The company has been struck off by the Registrar of Companies and is no longer operational.
Pharmacon Enterprises had 2 directors:
- Mohammad Ayub Khan - Managing Director
- Suhail Anwar - Director
The CIN (Corporate Identification Number) of Pharmacon Enterprises is U24239JK2009PTC003030. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Pharmacon Enterprises is at Shah Complex Opp. Medicare Diagonostic Center Karan Nagar, Srinagar, Jammu and Kashmir, India – 190010.
Pharmacon Enterprises was incorporated on 11 June 2009. It is registered with the Registrar of Companies, Jammu.
The latest financial statements of Pharmacon Enterprises on record with the MCA are for the year ended 31 March 2018. Its last annual general meeting was held on 29 September 2018. Year-wise statements from 2015 are in the company report.
Pharmacon Enterprises operated in the chemicals industry, in the medicinal chemical and botanical products segment. It worked in this industry before it was struck off.
The peers of Pharmacon Enterprises by revenue are Gyp Craft Frames Private Limited, Sangli Grape Processing Marketing and Research Industry Limited, Janta Fab Private Limited, Nucleus Microsystems Private Limited, Berryblues Retails Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Gazanfar Ali Jan ceased to be Director on 10 Jun 2019. Mohammad Saleem ceased to be Director on 30 Mar 2012. Yasir Sultan Khuroo ceased to be Director on 30 Mar 2012. Pharmacon Enterprises has 5 board changes on record in total.
The compliance status of Pharmacon Enterprises is compliant as of 11 July 2026.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
